Neuberger Berman Group LLC Gilead Sciences, Inc. Transaction History

Neuberger Berman Group LLC

$118 Billion
Q2 2024

A detailed history of Neuberger Berman Group LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 239,698 shares of GILD stock, worth $20 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

239,698

Previous 964,683 75.15%

Holding current value

$20 Million

Previous $70.7 Million 76.73%

% of portfolio

0.01%

Previous 0.06%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $45.8 Million - $52.8 Million	-724,985 Reduced 75.15%	239,698 $16.4 Million
Q1 2024 May 13, 2024	BUY	$71.58 - $87.29 $69.1 Million - $84.2 Million	964,683 New	964,683 $70.7 Million
Q4 2023 Feb 09, 2024	BUY	$73.27 - $83.09 $162 Million - $184 Million	2,213,739 Added 66.08%	5,564,068 $451 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $17.2 Million - $18.7 Million	232,409 Added 7.45%	3,350,329 $251 Million
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $23.5 Million - $26.8 Million	308,752 Added 10.99%	3,117,920 $240 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $200 Million - $228 Million	2,591,625 Added 1191.32%	2,809,168 $233 Million
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $2.36 Million - $3.38 Million	37,833 Added 21.05%	217,543 $18.7 Million
Q3 2022 Nov 15, 2022	SELL	$59.54 - $68.01 $9.36 Million - $10.7 Million	-157,256 Reduced 46.67%	179,710 $11.1 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $75.6 Million - $85.2 Million	-1,310,247 Reduced 79.54%	336,966 $20.9 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $81.3 Million - $102 Million	1,404,088 Added 577.52%	1,647,213 $97.6 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $3.53 Million - $4.01 Million	54,429 Added 28.84%	243,125 $16.5 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $539,218 - $581,756	7,966 Added 4.41%	188,696 $12.6 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $740,885 - $809,522	11,673 Added 6.9%	180,730 $12.1 Million
Q1 2021 May 13, 2021	SELL	$60.0 - $68.46 $81.8 Million - $93.3 Million	-1,362,582 Reduced 88.96%	169,057 $10.7 Million
Q4 2020 Feb 10, 2021	BUY	$56.65 - $64.55 $7.6 Million - $8.66 Million	134,094 Added 9.59%	1,531,639 $89.2 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $1.96 Million - $2.47 Million	31,597 Added 2.31%	1,397,545 $88.3 Million
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $9.65 Million - $11.2 Million	133,371 Added 10.82%	1,365,948 $105 Million
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $138 Million - $177 Million	-2,203,856 Reduced 64.13%	1,232,577 $92.1 Million
Q4 2019 Feb 12, 2020	SELL	$61.62 - $67.78 $18.1 Million - $19.9 Million	-293,109 Reduced 7.86%	3,436,433 $223 Million
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $9.26 Million - $10.2 Million	-148,087 Reduced 3.82%	3,729,542 $236 Million
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $11.4 Million - $12.8 Million	183,902 Added 4.98%	3,877,629 $262 Million
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $23 Million - $25.7 Million	367,209 Added 11.04%	3,693,727 $240 Million
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $4.35 Million - $5.67 Million	-71,811 Reduced 2.11%	3,326,518 $208 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $36.9 Million - $40.8 Million	-517,324 Reduced 13.21%	3,398,329 $262 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $42.5 Million - $49.5 Million	654,557 Added 20.07%	3,915,653 $277 Million
Q1 2018 May 08, 2018	BUY	$72.84 - $88.8 $13.1 Million - $16 Million	179,733 Added 5.83%	3,261,096 $246 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $12.6 Million - $14.8 Million	177,436 Added 6.11%	3,081,363 $221 Million
Q3 2017 Nov 15, 2017	BUY	$72.11 - $85.47 $209 Million - $248 Million	2,903,927	2,903,927 $235 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Gilead Sciences, Inc. Transaction History